Drug Discovery Biology
Other research themes
See the latest news
MIPS will be home to two researchers awarded close to $1M in funding through the ARC Discovery Early Career Researcher Award scheme.
Three outstanding mid-career researchers and new ARC Future Fellows, Associate Professor Darren Creek, Dr Nicholas Veldhuis and Dr Roey Elnathan have received close to $3M in funding to advance research projects addressing a range of medical needs.
The annual award honours an individual whose scientific contributions have had a major impact on research across all of biological chemistry.
Monash researchers, in collaboration with Queen Mary University of London, have published a state-of-the-art review on an emerging druggable target called FPR2, a key receptor involved in the regulation of inflammation.
A new study led by a team of Monash researchers working to develop a male contraceptive pill has identified that stinging nettle leaf extract has the potential to block a protein that controls the movement of sperm.
A new Monash biotech company called Phrenix Therapeutics has received funding to advance research to develop new therapeutics for cognitive disorders, particularly in schizophrenia.
A team of leading drug researchers have published a high impact review that sets out to provide guidance on how pre-clinical studies of diabetic heart failure should be designed to most closely mimic the human disease.
Her PhD thesis is entitled "Understanding structure and activation of GLP-1R".
World first: Researchers from Monash University have harnessed cutting-edge technology to fill key gaps in our understanding of how promising new therapeutics could work for the treatment of obesity.